NEJM Editorial on FDA Response to IOM Report

(That’s a lot of acronyms.)

Sheila Weiss Smith has an editorial in the new New England Journal of Medicine regarding what the FDA has done since the Institute of Medicine’s recommendations regarding improving drug safety last September.

–BC

(My usual disclosure: I do a small amount of consulting for for pharmaceutical companies involved in products liability litigation.)